NeuroTrax

Company Overview

Snapshot

Founded in November 2000 by Ely Simon, NeuroTrax operates with 1–10 employees. The company has raised $1.5 million across one funding round, attracting New Jersey Economic Development Authority as an investor. In June 2014, NeuroTrax's BrainCare platform became globally available, targeting brain wellness post-stroke and traumatic brain injury.

Business overview

NeuroTrax develops BrainCare, a cloud-based computer application designed for brain wellness. This platform provides clinicians with a series of interactive tests and associated reports to monitor brain fitness and offers data-driven recommendations for brain training. BrainCare assesses patient brain wellness by measuring accuracy and response time, comparing results against previous patient data and normative peer groups to identify cognitive strengths and weaknesses. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support, serving hospitals, clinics, and patients globally.

Strategic signal

In February 2020, a study highlighted that hyperbaric oxygen therapy (HBOT) protocols could improve cognitive function in stroke patients, a finding relevant to NeuroTrax's focus on brain wellness. This signals a potential for NeuroTrax's BrainCare platform to integrate with or complement emerging therapeutic approaches, offering objective assessment and monitoring tools to enhance patient outcomes in stroke recovery and cognitive rehabilitation.

Company Intelligence Q&A

What is NeuroTrax's primary product?

NeuroTrax's primary product is BrainCare, a cloud-based computer application that provides cognitive assessment through interactive tests and generates reports for monitoring brain fitness and recommending brain training.

When did NeuroTrax's BrainCare become globally available?

In June 2014, NeuroTrax's BrainCare platform became globally available, targeting brain wellness for individuals post-stroke and those with traumatic brain injury.

What was a significant finding related to cognitive function in February 2020?

In February 2020, a study demonstrated that hyperbaric oxygen therapy (HBOT) protocols could improve cognitive function in stroke patients, aligning with NeuroTrax's mission to promote brain wellness.

What was a key recognition for NeuroTrax in April 2008?

In April 2008, NJIT start-up company NeuroTrax was named "best in show," indicating early recognition for its innovative work.

What was the focus of a Medscape article featuring NeuroTrax in February 2018?

In February 2018, a Medscape article discussed how digital cognitive testing, such as that offered by NeuroTrax, can uncover hidden impairment in Multiple Sclerosis patients.